Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 71335-2378

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 71335-2378). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion-structure (Bupropion Structure)

Bupropion-structure (Bupropion Structure)
Chemical structure of bupropion hydrochloride showing the molecular arrangement including a chlorophenyl group, a tert-butylamino group, a ketone, and a hydrochloride moiety.*
FDA Label Image

Label (Lbl713352378)

Label (Lbl713352378)
Label for Bupropion Hydrochloride Extended-Release Tablets USP (XL) 150 mg, oral tablet dosage form. The label displays the NDC 71335-2378-1, quantity of 30 tablets, repackaged by Bryant Ranch Prepack and manufactured by Yichang Humanwell Oral Solid Dosage Plant. Storage instructions and a warning about co-use with ZYBAN or other bupropion products are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.